Table II.
AKR1B10 (ng/ml) | |||
---|---|---|---|
Characteristics | HCC (n=84) | Liver cirrhosis (n=74) | Chronic hepatitis (n=29) |
HBV infection | 4.17±3.69 (n=71) | 2.52±2.21 (n=41)a | 1.04±1.04 (n=17)a |
HCV infection | 3.27±2.56 (n=13) | 2.72±1.74 (n=33) | 1.24±1.00 (n=12)a,b |
P-value | 0.614 | 0.384 | 0.452 |
Data are presented as the mean ± standard deviation.
P<0.05 vs. patients with HCC.
P<0.05 vs. patients with liver cirrhosis. AKR1B10, aldo-keto reductase family 1 member B10; HCC, hepatocellular carcinoma; HBV, hepatitis B virus; HCV, hepatitis C virus.